Caliper Awarded Additional Task Order
Caliper Life Sciences, Inc. announced that its Caliper Discovery Alliances and Services unit has been awarded a new funding commitment for $2.9 million under its contract with the Environmental Protection Agency (EPA) for the EPA’s ToxCast screening program. Together with an initial Phase II task order awarded in November 2009, this new task order increases the cumulative funding Caliper has been awarded under Phase II of the ToxCast program to $4.7 million.
The long term goal of the EPA’s ToxCast program is to identify in vitro assays that can predict the toxicity of chemical compounds in humans and animals, by comparing the results of in vitro testing conducted by Caliper and others with the toxicity data in the EPA’s in vivo toxicity database, ToxRefDB, and then to employ those predictive tests to supplement or replace existing animal-based tests reducing cost and improving the speed of regulatory approval of new environmental chemicals. Caliper Life Sciences, Inc., 508-435-9500, http://www.caliperls.com/